Bolt Biotherapeutics, Inc. Gain (Loss) on Disposition of Assets
Bolt Biotherapeutics, Inc. (BOLT) reported Gain (Loss) on Disposition of Assets of $288.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-12
- Bolt Biotherapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $0.00.
- Bolt Biotherapeutics, Inc. gain (loss) on disposition of assets for fiscal 2025 was $288.00K, a 311.43% increase from fiscal 2024.
- Bolt Biotherapeutics, Inc. gain (loss) on disposition of assets for fiscal 2024 was $70.00K.
- Bolt Biotherapeutics, Inc. gain (loss) on disposition of assets for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|
| 2025-12-31 | $288.00K 10-K · filed 2026-03-12 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $70.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $70.00K 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |